NewAmsterdam Pharma Company N.V.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of NewAmsterdam Pharma Company N.V. generated cash of -$141,218,000, which is less than the previous year. Cash used in financing activities reached the amount of $8,912,000 last year. Net change in cash is therefore -$127,278,000.
Cash Flow
| 2020 | -5.97M | -13K | 11.32M |
|---|---|---|---|
| 2021 | -25.16M | -20K | 68.99M |
| 2022 | 7.97M | 715K | 375.17M |
| 2023 | -141.21M | -24K | 8.91M |
NAMS Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 467.72M | 53.09M | 7.86M | 2.5M |
Operating activities | ||||
Net income | -176.93M | -78.05M | -28.59M | -5.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 49K | 72K | 14K | 1K |
Stock-based compensation expense | 24.57M | 4.11M | 1.24M | 0 |
| Deferred income tax benefit | 24.57M | 4.11M | 1.24M | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | -3.90M | -4.60M | 0 |
Inventories | 0 | 5.92M | -135.48K | 0 |
Accounts payable | 5.07M | -2.02M | 8.57M | 48.3K |
Cash generated by operating activities | -141.21M | 7.97M | -25.16M | -5.97M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -24K | -13K | -20K | -13K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -24K | 715K | -20K | -13K |
Financing activities | ||||
Common Stock Issued | 7.33M | 396.95M | 69M | 114.37M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 747K | -10K | -13.92M |
Cash used in financing activities | 8.91M | 375.17M | 68.99M | 11.32M |
Net Change In Cash | -127.27M | 385.43M | 45.23M | 5.36M |
Cash at end of period | 340.45M | 438.52M | 53.09M | 7.86M |
| Data source | Data source |